bromodeoxyuridine has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiken, M; Glatstein, E; Hsu, SM; Kinsella, TJ; Mitchell, JB; Morstyn, G; Rowland, J; Russo, A | 1 |
| Landolt, AM | 1 |
2 other study(ies) available for bromodeoxyuridine and Thrombopenia
| Article | Year |
|---|---|
Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
Topics: Bone Marrow; Bromodeoxyuridine; Drug Eruptions; Drug Evaluation; Glioblastoma; Humans; Infusions, Parenteral; Neoplasms; Radiation-Sensitizing Agents; Thrombocytopenia; Time Factors | 1984 |
[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].
Topics: Adult; Aged; Alopecia; Brain Edema; Brain Neoplasms; Bromodeoxyuridine; Drug Interactions; Exanthema; Glioblastoma; Glossitis; Humans; Leukopenia; Methotrexate; Middle Aged; Postoperative Care; Prognosis; Radiation-Sensitizing Agents; Stomatitis; Thrombocytopenia | 1971 |